Evermay Wealth Management’s iShares Russell Mid-Cap Value ETF IWS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.7K Hold
107
﹤0.01% 454
2026
Q1
$15.6K Hold
107
﹤0.01% 416
2025
Q4
$15.1K Hold
107
﹤0.01% 410
2025
Q3
$15K Hold
107
﹤0.01% 414
2025
Q2
$14.2K Hold
107
﹤0.01% 417
2025
Q1
$13.5K Hold
107
﹤0.01% 414
2024
Q4
$13.9K Sell
107
-677
-86% -$90.6K ﹤0.01% 405
2024
Q3
$104K Sell
784
-491
-39% -$62K 0.02% 266
2024
Q2
$154K Sell
1,275
-35
-3% -$4.25K 0.02% 216
2024
Q1
$164K Buy
1,310
+1,256
+2,326% +$148K 0.02% 212
2023
Q4
$6.28K Hold
54
﹤0.01% 473
2023
Q3
$5.67K Hold
54
﹤0.01% 463
2023
Q2
$5.93K Hold
54
﹤0.01% 457
2023
Q1
$5.74K Hold
54
﹤0.01% 451
2022
Q4
$5.69K Hold
54
﹤0.01% 450
2022
Q3
$5K Buy
+54
New +$5.77K ﹤0.01% 442

Other funds holding IWS

Evermay Wealth Management's IWS Position: Q2 2026 in Review

Evermay Wealth Management held its iShares Russell Mid-Cap Value ETF (IWS) position steady in Q2 2026 at 107 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #454.

Evermay Wealth Management first reported a position in IWS in Q3 2022 and has held it in 16 quarters since. The position peaked at $164K in Q1 2024. 1,041 funds tracked by Wall St. Rank hold IWS as of Q2 2026.

  • Evermay Wealth Management held 107 shares of iShares Russell Mid-Cap Value ETF worth $17.7K as of Q2 2026.
  • Evermay Wealth Management left its iShares Russell Mid-Cap Value ETF share count unchanged in Q2 2026.
  • iShares Russell Mid-Cap Value ETF made up ﹤0.01% of Evermay Wealth Management's portfolio in Q2 2026, its #454 holding.
  • Evermay Wealth Management first reported a position in iShares Russell Mid-Cap Value ETF in Q3 2022 and has held it in 16 quarters since.
  • Evermay Wealth Management's iShares Russell Mid-Cap Value ETF position peaked at $164K in Q1 2024.
  • 1,041 funds tracked by Wall St. Rank held iShares Russell Mid-Cap Value ETF as of Q2 2026.

Based on Evermay Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.